The Government of Singapore, the European Molecular Biology Organization (EMBO) and its intergovernmental funding body, the European Molecular Biology Conference (EMBC), have signed a Cooperation Agreement to strengthen scientific interaction and collaborative research between Singapore and Europe. This milestone agreement marks the first time a non-European nation has become an EMBC Associate Member State.
As an EMBC Associate Member State, Singapore gains access to all of EMBO's activities, providing its scientists with the opportunity to interact with and benefit from the best scientists in Europe. The agreement brings together major players in Singapore's biomedical research scene, namely the Agency for Science, Technology and Research (A*STAR), the National University of Singapore (NUS), and Nanyang Technological University (NTU). Scientists can apply to all of EMBO's programmes, such as long-term fellowships for postdoctoral researchers, short-term fellowships, courses and workshops, as well as the EMBO Young Investigator Programme.
At the same time, Europe will benefit from closer interaction with the outstanding scientists in Singapore's research community. Greater cooperation between nations will help catalyse new discoveries and deliver world-class solutions for global issues.
